Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Docetaxel and Prednisone in Castration-Resistant Prostate Cancer
NCT01478308Phase 2Withdrawn
- Sponsor
- New Mexico Cancer Research Alliance
- Start
- Jun 2011
- Primary completion
- Oct 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in prostate cancer (PCa), sponsored by New Mexico Cancer Research Alliance. Planned start Jun 2011; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01478308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478308.